Literature DB >> 31205922

Immunity in cancer and atherosclerosis.

Petr Sima1, Luca Vannucci1, Vaclav Vetvicka2.   

Abstract

Cancer and cardiovascular diseases have been classified as non-communicable diseases for decades. Both diseases have characteristics of immune reactions, which are principally identical, but differing in important aspects. The aim of this communication is to highlight new approaches to immune processes involved in both types of diseases.

Entities:  

Keywords:  Cancer; cardiovascular diseases; immunity; immunosurveillance

Year:  2019        PMID： 31205922      PMCID： PMC6545310          DOI： 10.21037/atm.2019.04.56

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


  6 in total

1.  Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment.

Authors:  Lin-Hui Yang; Li-Zhen Xu; Zhi-Jian Huang; Hong-Hong Pan; Min Wu; Qiu-Yan Wu; Tao Lu; Yan-Ping Zhang; Yao-Bin Zhu; Jia-Bin Wu; Jie-Wei Luo; Guo-Kai Yang; Lie-Fu Ye
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC).

Authors:  Guang-Zhao Huang; Qing-Qing Wu; Ze-Nan Zheng; Ting-Ru Shao; Fei Li; Xin-Yan Lu; Heng-Yu Ye; Gao-Xiang Chen; Yu-Xing Song; Wei-Sen Zeng; Yi-Long Ai; Xiao-Zhi Lv
Journal:  Onco Targets Ther       Date:  2021-02-25       Impact factor: 4.147

3.  CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.

Authors:  Qiliu Peng; Hai Huang; Chunling Zhu; Qingqing Hou; Shangmou Wei; Yi Xiao; Zhi Zhang; Xing Sun
Journal:  Oxid Med Cell Longev       Date:  2022-09-19       Impact factor: 7.310

4.  Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.

Authors:  Wenbiao Chen; Minglin Ou; Donge Tang; Yong Dai; Weibo Du
Journal:  J Immunol Res       Date:  2020-03-07       Impact factor: 4.818

5.  Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.

Authors:  Jinzhi Lai; Tianwen Xu; Hainan Yang
Journal:  BMC Cancer       Date:  2022-03-25       Impact factor: 4.430

6.  A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.

Authors:  Zijia Tao; Enchong Zhang; Lei Li; Jianyi Zheng; Yiqiao Zhao; Xiaonan Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.